Alloimmunization following allogenic heamtopoietis stem cell transplantation

Raos, Mirela; Bojanić, Ines; Serventi Seiwerth, Ranka; Golubić Ćepulić, Branka

Pregled bibliografske jedinice broj: 1170071

Alloimmunization following allogenic heamtopoietis stem cell transplantation

Raos, Mirela; Bojanić, Ines; Serventi Seiwerth, Ranka; Golubić Ćepulić, Branka

Alloimmunization following allogenic heamtopoietis stem cell transplantation // 35th International Congress of the ISBT
Toronto, Kanada, 2018. str. 225-226 (predavanje, podatak o recenziji nije dostupan, sažetak, ostalo)

CROSBI ID: 1170071 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Alloimmunization following allogenic heamtopoietis stem cell transplantation

Autori
Raos, Mirela ; Bojanić, Ines ; Serventi Seiwerth, Ranka ; Golubić Ćepulić, Branka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo

Skup
35th International Congress of the ISBT

Mjesto i datum
Toronto, Kanada, 02.06.2018. - 06.06.2018

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Podatak o recenziji nije dostupan

Ključne riječi
alloimmunization, allogenic heamtopoietis, stem cell transplantation

Sažetak
In patients treated with allogeneic HSCT, there is a risk ofdeveloping new alloimmunization, due to exposure of donor lymphocytes to RBC ofthe recipient, or transfusion therapy with antigen incompatible blood components.After allogeneic HSCT, our patients developed alloantibodies of the Rhesus, Kell, MNS and Lutheran blood group systems that can cause significant hemolysis andcomplicate the course of recovery. Since some patients develop alloantibodiesdespite intensive immunosuppressive treatment, continuous immunohematologicalmonitoring is required for patients following HSCT.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

POVEZANOST RADA

Ustanove:
Klinički bolnički centar Zagreb

Profili:

Ranka Serventi-Seiwerth (autor)